Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance

Current antileishmanial treatment is hampered by limitations, such as drug toxicity and the risk of treatment failure, which may be related to parasitic drug resistance. Given the urgent need for novel drugs, the Drugs for Neglected Diseases initiative (DNDi) has undertaken a drug discovery program,...

Descripción completa

Detalles Bibliográficos
Autores principales: Van den Kerkhof, M., Mabille, D., Hendrickx, S., Leprohon, P., Mowbray, C. E., Braillard, S., Ouellette, M., Maes, L., Caljon, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Mechanisms of Resistance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449183/
https://www.ncbi.nlm.nih.gov/pubmed/32601168
http://dx.doi.org/10.1128/AAC.00152-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449183/
https://www.ncbi.nlm.nih.gov/pubmed/32601168
http://dx.doi.org/10.1128/AAC.00152-20

Ejemplares similares